Additionally, the ability of AST to downregulate NF-κB protein expression aligns with its effects in a model of subarachnoid hemorrhage [83], supporting its potential as an anti-autistic agent by reducing one of the inflammatory markers associated with autism [79]. This evidence concerns the gene NFKB1 and subarachnoid hemorrhage.